Actinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Actimab-A
May 24, 2017 13:26 pm UTC| Business
- Orphan designation provides increased communication and guidance from regulators and 10-year market exclusivity upon marketing authorization -Actinium’s two leading drug candidates, Iomab-B and Actimab-A, now have orphan...
May 24, 2017 13:25 pm UTC| Business
ALHAMBRA, Calif., May 24, 2017 -- EMCORE Corporation (NASDAQ:EMKR), a leading provider of advanced Mixed-Signal Optics products that provide the foundation for today’s high-speed communication network infrastructures...
May 24, 2017 13:25 pm UTC| Business
ALHAMBRA, Calif., May 24, 2017 -- EMCORE Corporation (NASDAQ:EMKR), a leading provider of advanced Mixed-Signal Optics products that provide the foundation for today’s high-speed communication network infrastructures...
May 24, 2017 13:25 pm UTC| Business
ALHAMBRA, Calif., May 24, 2017 -- EMCORE Corporation (NASDAQ:EMKR), a leading provider of advanced Mixed-Signal Optics products that provide the foundation for today’s high-speed communication network infrastructures...
May 24, 2017 13:25 pm UTC| Business
ALHAMBRA, Calif., May 24, 2017 -- EMCORE Corporation (NASDAQ:EMKR), a leading provider of advanced Mixed-Signal Optics products that provide the foundation for today’s high-speed communication network infrastructures...
May 24, 2017 13:25 pm UTC| Business
ALHAMBRA, Calif., May 24, 2017 -- EMCORE Corporation (NASDAQ:EMKR), a leading provider of advanced Mixed-Signal Optics products that provide the foundation for today’s high-speed communication network infrastructures...
Onosys Experiences Significant Growth During First Year Under New Leadership Team
May 24, 2017 13:24 pm UTC| Business
CLEVELAND, May 24, 2017 -- Onosys today announced the successful completion of several significant milestones since its acquisition by Splick.it, Inc. in May 2016. From the unveiling of its new brand and the...